Correlation Between Biotechnology Portfolio and Science Technology

Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Science Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Science Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Science Technology Fund, you can compare the effects of market volatilities on Biotechnology Portfolio and Science Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Science Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Science Technology.

Diversification Opportunities for Biotechnology Portfolio and Science Technology

-0.43

Correlation Coefficient

Biotechnology Portfolio  Science Technology

Very good diversification

The 3 months correlation between Biotechnology and Science is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Science Technology Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Science Technology and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Science Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Science Technology has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Science Technology go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Science Technology

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to under-perform the Science Technology. But the mutual fund apears to be less risky and, when comparing its historical volatility, Biotechnology Portfolio Biotechnology is 1.14 times less risky than Science Technology. The mutual fund trades about -0.21 of its potential returns per unit of risk. The Science Technology Fund is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2,919  in Science Technology Fund on October 22, 2024 and sell it today you would lose (10.00) from holding Science Technology Fund or give up 0.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biotechnology Portfolio Biotec  vs.  Science Technology Fund

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Science Technology

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Science Technology Fund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak fundamental indicators, Science Technology may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Biotechnology Portfolio and Science Technology

The main advantage of trading using opposite Biotechnology Portfolio and Science Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Science Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Science Technology will offset losses from the drop in Science Technology's long position.

The idea behind Biotechnology Portfolio Biotechnology and Science Technology Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.